PALISADE BIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
PALISADE BIO, INC. (PALI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 3.71 million shares for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-09.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2016-05-09
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-03-31 was 3.71M shares, a 656.34% increase year-over-year.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2015-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2015-09-30 was 224.65K shares, a 35.80% decline year-over-year.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2015-06-30 was 50.00K shares, a 52.38% decline year-over-year.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2015 was 765.55K shares, a 24.55% decline from fiscal 2014.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2014 was 1.01M shares, a 73.58% decline from fiscal 2013.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2013 was 3.84M shares, a 20.76% decline from fiscal 2012.
- PALISADE BIO, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2012 was 4.85M shares, a 2703.39% increase from fiscal 2011.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2016-03-31 | 3.71M shares 10-Q · filed 2016-05-09 | 3.71M shares derived: sum of 2 quarters · filed 2016-05-09 | 3.94M shares derived: sum of 3 quarters · filed 2016-05-09 | 3.99M shares derived: sum of 4 quarters · filed 2016-05-09 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 224.65K shares derived: sum of 2 quarters · filed 2016-03-14 | 274.65K shares derived: sum of 3 quarters · filed 2016-03-14 | 765.55K shares 10-K · filed 2016-03-14 |
| 2015-09-30 | 224.65K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 274.65K shares derived: sum of 2 quarters · filed 2015-11-09 | 765.55K shares 10-Q · filed 2015-11-09 | 916.85K shares derived: sum of 4 quarters · filed 2015-11-09 |
| 2015-06-30 | 50.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | 540.90K shares 10-Q · filed 2015-08-10 | 692.20K shares derived: sum of 3 quarters · filed 2015-08-10 | 1.04M shares derived: sum of 4 quarters · filed 2015-08-10 |
| 2015-03-31 | 490.90K shares 10-Q · filed 2015-05-08 | 642.20K shares derived: sum of 2 quarters · filed 2015-05-08 | 992.11K shares derived: sum of 3 quarters · filed 2015-05-08 | 1.10M shares derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-12-31 | 151.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | 501.21K shares derived: sum of 2 quarters · filed 2015-03-16 | 606.21K shares derived: sum of 3 quarters · filed 2015-03-16 | 1.01M shares 10-K · filed 2015-03-16 |
| 2014-09-30 | 349.91K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | 454.91K shares derived: sum of 2 quarters · filed 2014-11-07 | 863.39K shares 10-Q · filed 2014-11-07 | 3.20M shares derived: sum of 4 quarters · filed 2014-11-07 |
| 2014-06-30 | 105.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | 513.48K shares 10-Q · filed 2014-08-08 | 2.85M shares derived: sum of 3 quarters · filed 2014-08-08 | 2.85M shares derived: sum of 4 quarters · filed 2014-08-08 |
| 2014-03-31 | 408.48K shares 10-Q · filed 2014-05-12 | 2.75M shares derived: sum of 2 quarters · filed 2014-05-12 | 2.75M shares derived: sum of 3 quarters · filed 2014-05-12 | 2.85M shares derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | 2.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | 2.34M shares derived: sum of 2 quarters · filed 2014-03-10 | 2.44M shares derived: sum of 3 quarters · filed 2014-03-10 | 3.84M shares 10-K · filed 2014-03-10 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 105.00K shares derived: sum of 2 quarters · filed 2013-11-12 | 1.50M shares 10-Q · filed 2013-11-12 | 1.50M shares derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | 105.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 1.50M shares 10-Q · filed 2013-08-08 | 1.50M shares derived: sum of 3 quarters · filed 2013-08-08 | 4.50M shares derived: sum of 4 quarters · filed 2013-08-08 |
| 2013-03-31 | 1.40M shares 10-Q · filed 2013-05-10 | 1.40M shares derived: sum of 2 quarters · filed 2013-05-10 | 4.40M shares derived: sum of 3 quarters · filed 2013-05-10 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | 3.00M shares derived: sum of 2 quarters · filed 2013-03-15 | 4.85M shares 10-K · filed 2013-03-15 | |
| 2012-09-30 | 3.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | 4.85M shares 10-Q · filed 2012-11-09 | ||
| 2012-06-30 | 1.85M shares 10-Q · filed 2012-08-09 | |||
| 2011-12-31 | 172.92K shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |